查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401824

仿製药合约製造市场，按材料类型、按应用、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Generic Injectable Pharmaceutical Contract Manufacturing Market, By Material Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年仿製药合约製造市场规模为 101 亿美元，2023 年至 2030 年复合CAGR为 11.2%。

仿製药合约製造市场-市场动态

医药产业製造需求加大医药研发投入拉动市场需求

该市场的扩张主要源于製药业复杂的製造需求、药品研发投资的增加、对先进技术的日益青睐、专利到期以及冠状病毒大流行的影响。此外，对细胞和基因疗法、个人化药物的需求不断增长，以及高效活性药物成分（HPAPI）和抗体药物偶联物（ADC）市场的激增，预计将为市场参与者带来重大机会。对具有成本效益的仿製药注射药物的需求持续增长，加上全球医疗保健系统对此类药物的持续需求，推动了该细分市场的成长。各个利益相关者相互协作，以满足监管标准，确保生产质量，并满足医疗保健对可获取且负担得起的注射药物的需求。

仿製药注射药品合约製造市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2023-2030 年）每年将以 11.2% 左右的CAGR成长

根据材料类型细分，预计大分子将在 2022 年显示最大的市场份额

从应用细分来看，肿瘤学是2022年的主导类型

按地区划分，北美是 2022 年的主要收入来源

仿製药合约製造市场-細項分析：

全球仿製药注射药品合约製造市场根据材料类型、应用、最终用户和地区进行细分。

市场依材料类型分为两类：小分子和大分子。根据材料类型，2022 年的重要收入份额由大分子细分市场占据。对客製化治疗和精准医疗的大力关注极大地促进了美国大分子仿製药注射药物细分市场的成长。此外，包括生物相似药在内的产品上市的增加也显着支持了细分市场的扩张。例如，2023年1月，安进在美国推出了修美乐（Humira）的生物仿製药AMJEVITA，这是美国FDA批准的第一个仿製药修美乐（Humira）版本，显示了预计将促进细分市场成长的因素。

依应用市场分为七类：肿瘤学、免疫学、抗糖尿病。神经病学、心血管病学、呼吸病学等。根据应用情况，肿瘤学领域在 2022 年获得了最大的收入份额。这归因于越来越多地推出针对癌症治疗的仿製药产品。许多合约製造商正致力于开发用于抗癌治疗的仿製药注射剂。此外，用于抗癌治疗的大量仿製药产品正在开发中，其中几种仿製药计划引入市场。

仿製药注射药品合约製造市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。

仿製药合约製造市场-竞争格局：

在仿製药合约製造市场的竞争领域，公司采用多方面的策略来确保其突出地位和生存能力。这些实体优先考虑成本效益，精心调整製造流程，以具有竞争力的价格提供高品质的仿製药注射药物。品质和合规性仍然是不容谈判的，坚定地致力于满足 cGMP 等严格的监管标准，推动对尖端技术和现代化设施的投资。服务多样化是一个关键追求，因为合约製造商扩大了其产品范围，涵盖各种注射剂形式，以满足不同的客户需求和市场需求。同时，对研发的高度重视推动创新，寻求製造技术、配方和药物传递系统的进步，以在不断发展的环境中保持领先地位。建立策略伙伴关係和联盟，促进与寻求外包解决方案的製药公司的长期合作，确保共同成长和稳定。此外，全球视野推动了扩张计划，在不同地区建立製造中心，以满足更广泛的市场，同时遵守地区法规。总的来说，这些策略使这些公司能够驾驭製药业复杂的动态，推动仿製药注射药品合约製造市场的竞争力和持续成长。

最近的发展：

2023 年 3 月，生物製药合约製造商 PCI Pharma Services 披露，计划投资 5,000 万美元扩建其位于伊利诺伊州罗克福德的无菌注射剂工厂。

目录

第 1 章：仿製药注射药品合约製造市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按材料类型分類的通用注射药品合约製造市场片段
    • 按应用分类的仿製药合约製造市场片段
    • 最终用户的仿製药合约製造市场片段
    • 按国家/地区分類的仿製药合约製造市场片段
    • 按地区分類的仿製药合约製造市场片段
  • 竞争洞察

第 3 章：仿製药注射药品合约製造主要市场趋势

  • 仿製药合约製造市场驱动因素
    • 市场驱动因素的影响分析
  • 仿製药注射药品合约製造市场限制
    • 市场限制影响分析
  • 仿製药注射剂合约製造市场机会
  • 仿製药合约製造市场未来趋势

第 4 章：仿製药注射药品合约製造业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：仿製药注射药品合约製造市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：仿製药注射药品合约製造市场格局

  • 2022 年仿製药注射药品合约製造市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：仿製药注射药品合约製造市场 - 按材料类型

  • 概述
    • 按材料类型分類的细分市场份额分析
    • 小分子
    • 大分子

第 8 章：仿製药注射药品合约製造市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 肿瘤学
    • 免疫学
    • 抗糖尿病
    • 神经病学
    • 心血管
    • 呼吸系统
    • 其他的

第 9 章：仿製药注射药品合约製造市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 大型製药公司
    • 中小型製药公司
    • 仿製药公司
    • 其他的

第 10 章：仿製药注射药品合约製造市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美仿製药注射剂合约製造主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按材料类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲仿製药注射剂合约製造主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按材料类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区仿製药注射剂合约製造主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模和预测（按材料类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲注射剂仿製药合约製造主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按材料类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲仿製药注射合约製造主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按材料类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 仿製药注射药品合约製造业

  • 竞争仪表板
  • 公司简介
    • Hikma Pharmaceuticals plc
    • Pfizer Inc.
    • Fresenius Kabi
    • Sandoz AG
    • Jubilant Pharma Limited
    • Baxter
    • PCI Pharma Services
    • Gland Pharma Limited (USA)
    • Dr. Reddy's Laboratories Ltd.
    • Grand River Aseptic Manufacturing
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2032

REPORT HIGHLIGHT

Generic Injectable Pharmaceutical Contract Manufacturing Market size was valued at USD 10,100 Million in 2022, expanding at a CAGR of 11.2% from 2023 to 2030.

Generic Injectable Pharmaceutical Contract Manufacturing involves specialized contract manufacturers producing non-brand name injectable medications (e.g., intravenous, intramuscular, or subcutaneous routes) for pharmaceutical companies. This sector thrives on intricate manufacturing demands, investments in R&D, technological advancements, patent expirations, and pandemic impacts. It caters to cell and gene therapies, personalized medicines, HPAPI, and ADC markets. With a growing demand for cost-effective injectable drugs and an ongoing need in global healthcare, stakeholders collaborate to ensure regulatory compliance, quality production, and accessibility to affordable medications. Key segments include large molecule drugs (e.g., biosimilars) and oncology-focused products, witnessing continuous growth and innovation in the pharmaceutical market.

Generic Injectable Pharmaceutical Contract Manufacturing Market- Market Dynamics

Manufacturing demands of the pharmaceutical industry, heightened investments in pharmaceutical research and development to propel market demand

The expansion of this market primarily stems from the intricate manufacturing demands of the pharmaceutical industry, heightened investments in pharmaceutical research and development (R&D), a growing inclination towards advanced technologies, patent expirations, and the impact of the coronavirus pandemic. Moreover, the rising demand for cell and gene therapies, personalized medicines, as well as the surge in the High-potency Active Pharmaceutical Ingredients (HPAPI) and Antibody-drug Conjugates (ADC) markets, is anticipated to present significant opportunities for market participants. The continued increase in demand for cost-effective generic injectable drugs, coupled with the ongoing necessity for such medications within global healthcare systems, propels the growth of this market segment. Various stakeholders collaborate to meet regulatory standards, ensure quality production, and address healthcare needs for accessible and affordable injectable medications.

Generic Injectable Pharmaceutical Contract Manufacturing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.2% over the forecast period (2023-2030)

Based on Material Type segmentation, large molecule was predicted to show maximum market share in the year 2022

Based on application segmentation, Oncology was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Generic Injectable Pharmaceutical Contract Manufacturing Market- Segmentation Analysis:

The Global Generic Injectable Pharmaceutical Contract Manufacturing Market is segmented on the basis of Material Type, Application, End User, and Region.

The market is divided into two categories based on Material Type: Small Molecule and large Molecule. Based on material type, the significant revenue share in 2022 was held by the large molecule segment. The substantial focus on customized treatments and precision medicine significantly contributes to the growth of the large molecule generic injectable drugs segment in the U.S. Furthermore, the rise in product launches, including biosimilars, notably supports segment expansion. For instance, in January 2023, Amgen introduced AMJEVITA, a biosimilar to Humira, in the U.S. It was the first generic version of Humira approved by the U.S. FDA, indicative of factors expected to bolster segment growth.

The market is divided into seven categories based on application: Oncology, Immunology, Antidiabetic. Neurology, Cardiovascular, Respiratory and Others. Based on application, the oncology segment secured the largest revenue share in 2022. This is attributed to the increasing launch of generic products tailored for cancer treatment. Numerous contract manufacturers are concentrating on developing generic injectables for anti-cancer therapy. Additionally, a considerable pipeline of generic products for anti-cancer therapies is in progress, with several generic drugs slated for introduction into the market.

Generic Injectable Pharmaceutical Contract Manufacturing Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Generic Injectable Pharmaceutical Contract Manufacturing Market- Competitive Landscape:

In the competitive realm of the Generic Injectable Pharmaceutical Contract Manufacturing Market, companies employ multifaceted strategies to ensure their prominence and viability. These entities prioritize cost-effectiveness, meticulously fine-tuning manufacturing processes to deliver high-quality generic injectable medications at competitive prices. Quality and compliance remain non-negotiable, with a steadfast commitment to meeting stringent regulatory standards such as cGMP, driving investments in cutting-edge technologies and modern facilities. Diversification of services is a key pursuit, as contract manufacturers broaden their offerings to encompass various injectable formats, accommodating diverse client needs and market demands. Simultaneously, heavy emphasis on research and development fuels innovation, seeking advancements in manufacturing techniques, formulations, and drug delivery systems to stay ahead in the evolving landscape. Strategic partnerships and alliances are forged, fostering long-term collaborations with pharmaceutical firms seeking outsourcing solutions, ensuring mutual growth and stability. Moreover, a global outlook propels expansion initiatives, establishing manufacturing hubs in different regions to cater to a broader market while complying with regional regulations. Collectively, these strategies enable these companies to navigate the intricate dynamics of the pharmaceutical industry, driving competitiveness and sustained growth within the Generic Injectable Pharmaceutical Contract Manufacturing Market.

Recent Developments:

In March 2023, PCI Pharma Services, a biopharmaceutical contract manufacturer, disclosed plans to invest USD 50 million in expanding its sterile injectables facility situated in Rockford, Illinois.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENERIC INJECTABLE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET KEY PLAYERS

  • Hikma Pharmaceuticals plc
  • Pfizer Inc.
  • Fresenius Kabi
  • Sandoz AG
  • Jubilant Pharma Limited
  • Baxter
  • PCI Pharma Services
  • Gland Pharma Limited (USA)
  • Dr. Reddy's Laboratories Ltd.
  • Grand River Aseptic Manufacturing
  • Others

GLOBAL GENERIC INJECTABLE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY MATERIAL TYPE

  • Small Molecule
  • Large Molecule

GLOBAL GENERIC INJECTABLE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY APPLICATION

  • Oncology
  • Immunology
  • Antidiabetic
  • Neurology
  • Cardiovascular
  • Respiratory
  • Others

GLOBAL GENERIC INJECTABLE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER

  • Big Pharmaceutical Companies
  • Small & Mid Sized Pharmaceutical Companies
  • Generic Pharmaceutical Companies
  • Others

GLOBAL GENERIC INJECTABLE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Generic Injectable Pharmaceutical Contract Manufacturing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Generic Injectable Pharmaceutical Contract Manufacturing Market Snippet by Material Type
    • 2.1.2. Generic Injectable Pharmaceutical Contract Manufacturing Market Snippet by Application
    • 2.1.3. Generic Injectable Pharmaceutical Contract Manufacturing Market Snippet by End User
    • 2.1.4. Generic Injectable Pharmaceutical Contract Manufacturing Market Snippet by Country
    • 2.1.5. Generic Injectable Pharmaceutical Contract Manufacturing Market Snippet by Region
  • 2.2. Competitive Insights

3. Generic Injectable Pharmaceutical Contract Manufacturing Key Market Trends

  • 3.1. Generic Injectable Pharmaceutical Contract Manufacturing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Generic Injectable Pharmaceutical Contract Manufacturing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Generic Injectable Pharmaceutical Contract Manufacturing Market Opportunities
  • 3.4. Generic Injectable Pharmaceutical Contract Manufacturing Market Future Trends

4. Generic Injectable Pharmaceutical Contract Manufacturing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Generic Injectable Pharmaceutical Contract Manufacturing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Generic Injectable Pharmaceutical Contract Manufacturing Market Landscape

  • 6.1. Generic Injectable Pharmaceutical Contract Manufacturing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Generic Injectable Pharmaceutical Contract Manufacturing Market - By Material Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Material Type, 2022 & 2030 (%)
    • 7.1.2. Small Molecule
    • 7.1.3. Large Molecule

8. Generic Injectable Pharmaceutical Contract Manufacturing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Oncology
    • 8.1.3. Immunology
    • 8.1.4. Antidiabetic
    • 8.1.5. Neurology
    • 8.1.6. Cardiovascular
    • 8.1.7. Respiratory
    • 8.1.8. Others

9. Generic Injectable Pharmaceutical Contract Manufacturing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 9.1.2. Big Pharmaceutical Companies
    • 9.1.3. Small & Mid Sized Pharmaceutical Companies
    • 9.1.4. Generic Pharmaceutical Companies
    • 9.1.5. Others

10. Generic Injectable Pharmaceutical Contract Manufacturing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Generic Injectable Pharmaceutical Contract Manufacturing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Generic Injectable Pharmaceutical Contract Manufacturing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Generic Injectable Pharmaceutical Contract Manufacturing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Generic Injectable Pharmaceutical Contract Manufacturing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Generic Injectable Pharmaceutical Contract Manufacturing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Generic Injectable Pharmaceutical Contract Manufacturing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Hikma Pharmaceuticals plc
    • 11.2.2. Pfizer Inc.
    • 11.2.3. Fresenius Kabi
    • 11.2.4. Sandoz AG
    • 11.2.5. Jubilant Pharma Limited
    • 11.2.6. Baxter
    • 11.2.7. PCI Pharma Services
    • 11.2.8. Gland Pharma Limited (USA)
    • 11.2.9. Dr. Reddy's Laboratories Ltd.
    • 11.2.10. Grand River Aseptic Manufacturing
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Generic Injectable Pharmaceutical Contract Manufacturing Market: Material Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Material Type
  • TABLE Global Generic Injectable Pharmaceutical Contract Manufacturing Market, by Material Type 2018-2030 (USD Million)
  • TABLE Generic Injectable Pharmaceutical Contract Manufacturing Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Generic Injectable Pharmaceutical Contract Manufacturing Market, by Application 2018-2030 (USD Million)
  • TABLE Generic Injectable Pharmaceutical Contract Manufacturing Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Generic Injectable Pharmaceutical Contract Manufacturing Market, by End User 2018-2030 (USD Million)
  • TABLE Generic Injectable Pharmaceutical Contract Manufacturing Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Generic Injectable Pharmaceutical Contract Manufacturing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Generic Injectable Pharmaceutical Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Generic Injectable Pharmaceutical Contract Manufacturing Market, by Material Type, 2018-2030 (USD Million)
  • TABLE North America Generic Injectable Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Generic Injectable Pharmaceutical Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Generic Injectable Pharmaceutical Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Generic Injectable Pharmaceutical Contract Manufacturing Market, by Material Type, 2018-2030 (USD Million)
  • TABLE Europe Generic Injectable Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Generic Injectable Pharmaceutical Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Injectable Pharmaceutical Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Injectable Pharmaceutical Contract Manufacturing Market, by Material Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Injectable Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Injectable Pharmaceutical Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Generic Injectable Pharmaceutical Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Generic Injectable Pharmaceutical Contract Manufacturing Market, by Material Type, 2018-2030 (USD Million)
  • TABLE Latin America Generic Injectable Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Generic Injectable Pharmaceutical Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Injectable Pharmaceutical Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Injectable Pharmaceutical Contract Manufacturing Market, by Material Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Injectable Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Injectable Pharmaceutical Contract Manufacturing Market, by End User, 2018-2030 (USD Million)